Home » PROMETIC CLOSES C$10.8 MILLION PRIVATE PLACEMENT
PROMETIC CLOSES C$10.8 MILLION PRIVATE PLACEMENT
ProMetic Life Sciences Inc. announced today that it closed a previously announced private placement of 29,600,000 subordinate voting shares at C$0.365 per share with JPMorgan and Third Point LLC. Proceeds from the private placement totaled C$10.8 million.
Market Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May